Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up

NCT: NCT05887700 · RECRUITING

NCT IDNCT05887700
StatusRECRUITING
Start Date2024-07-09
Completion2027-06-30

Brief Summary

The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.

Frequently Asked Questions

What is Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up?

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up is a clinical trial registered under NCT05887700. Current status: RECRUITING.

What is the status of NCT05887700?

The current status of NCT05887700 (Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up) is: RECRUITING.

When did Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up start?

Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up started on 2024-07-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.